Sr. AD, Medical Affairs Strategy Team Member

BoehringerPRD•Brampton, ON

12d•$200,000 - $316,000

About The Position

The Senior Associate Director, Oncology Medical Affairs Strategy Team Member, serves as the subject matter expert for assigned product to create the indication-specific or product-specific medical strategic framework and prioritized medical tactics to ensure the success of the respective BI product(s) from a Medical Affairs perspective, both prior to and leading up to launch, as well as throughout the product lifecycle. This individual will bring together strong scientific knowledge of the therapeutic area, strong command of the relevant clinical practice guidelines and related scientific data, as well as the understanding of the overall TA priorities and value drivers into an integrated strategic medical plan and tactics that enable the successful medical affairs contribution to BI’s portfolio and informs clinical development efforts where applicable. The Senior Associate Director, Medical Affairs Strategy Team Member, collaborates cross functionally within the larger Clinical Development & Medical Affairs (CDMA) department (e.g., Medicine Excellence, Field Medical Affairs, RWE, Publications, etc.) and across the organization (e.g.,Marketing, Market Access, Analytics & Insights (A&I), HEOR, Clinical Operations, Patient Services, Legal, Compliance, etc.) and with global counterparts to create, execute, measure and adapt the Medical Affairs strategy to best fit the needs of the US clinical landscape and market dynamics of relevance to the respective TA.

Requirements

Bachelor’s degree required, and in addition fulfill one of the following education levels: Seven (7) years of professional experience in a scientific, clinical, and/or medical affairs space, including five (5) years in relevant strategic position in pharmaceutical or related industry.
One-plus (1+) years of experience in Medical Affairs, Clinical Trials, Regulatory, or related area supporting oncology therapeutic area
Experience in neuroendocrine neoplasms, including small cell lung cancer (SCLC), extrapulmonary neuroendocrine carcinomas (epNEC), rare tumors, and related disease areas strongly preferred
Demonstrated experience with pharmaceutical drug development and the use of data analysis for strategy development, business process improvement, product launch planning, and integrated evidence generation required.
Demonstrated success leading publication and scientific communications programs, including compliant dissemination of clinical and scientific data
Strong experience developing and executing publication strategies, expert engagement plans, advisory boards, medical education initiatives, and congress/symposium activities
Proven ability to leverage omnichannel engagement strategies and apply insights, analytics, and performance metrics to enhance Medical Affairs effectiveness and impact.
Ability to translate scientific and medical market insights into medical tactical plans for effective launches of pharmaceutical products in the US, integrated evidence generation plans, and optimized medical strategies.
Demonstrated ability to collaborate cross-functionally to enable successful execution and deliver results in a deadline-driven environment while managing multiple priorities.
Strong understanding of oncology TA and shifting US healthcare environment, medical, pharmaceutical and payor market dynamics, portfolio growth, and ability to manage multiple projects and identify risks in a fast-paced environment with a drive for results and sense of urgency to meet medical market needs.
Ability to collaborate, influence, and establish strategic direction as well as drive effective execution.
Ability to travel with some overnights away from home as required by the nature of the role.
Must be legally authorized to work in the United States without restriction.
Must be willing to take a drug test and post-offer physical (if required).
Must be 18 years of age or older.

Nice To Haves

Experience in neuroendocrine neoplasms, including small cell lung cancer (SCLC), extrapulmonary neuroendocrine carcinomas (epNEC), rare tumors, and related disease areas strongly preferred

Responsibilities

Partners with US and Global teams to develop launch strategies and integrated evidence plans that address key evidence gaps for assigned oncology products.
Executes medical tactics, data releases, and evidence-generation initiatives aligned with BI/CDMA objectives, clinical development, and the evolving US healthcare landscape.
Collaborates across Medical, Commercial, GTM, CDMA, and Clinical Development teams to support asset planning, launch readiness, and lifecycle strategy.
Drives medical strategy by identifying opportunities and risks, incorporating stakeholder insights, and aligning cross-functional execution.
Leads publication, scientific communication, congress, and medical education strategies to maximize the impact of clinical and scientific data.
Designs and leads advisory boards, expert engagements, and insight-generation activities that inform strategic decision-making.
Applies omnichannel engagement approaches to optimize scientific exchange, medical education, and evidence dissemination.
Partners with internal stakeholders to optimize budget planning and advance digital, hybrid, and omnichannel capabilities.
Represents the CDMA TA team in business planning and governance activities, helping define strategic priorities, KPIs, and success measures.
Leads TA-specific strategic initiatives that enhance business agility, customer focus, and compliance.
Develops medical tools, materials, and communication strategies for organized customers, Payers/Systems, and AMAs in collaboration with Value/Access and Health Systems teams.